BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38364098)

  • 1. Evaluation of CHROMagar
    Bentz ML; Le N; Min B; Nunnally NS; Sullivan V; Tran M; Lockhart SR; Litvintseva A; Berkow EL; Sexton DJ
    Microbiol Spectr; 2024 Apr; 12(4):e0356423. PubMed ID: 38364098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHROMagarTM Candida Plus: A novel chromogenic agar that permits the rapid identification of Candida auris.
    Borman AM; Fraser M; Johnson EM
    Med Mycol; 2021 Mar; 59(3):253-258. PubMed ID: 32525988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Chromogenic Medium CHROMagar
    Mulet Bayona JV; Salvador García C; Tormo Palop N; Valentín Martín A; González Padrón C; Colomina Rodríguez J; Pemán J; Gimeno Cardona C
    J Fungi (Basel); 2022 Mar; 8(3):. PubMed ID: 35330283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of Chromogenic Media with Fluconazole Supplementation for Presumptive Identification of
    Ruiz-Gaitán A; Sigona-Giangreco I; Pérez-Royo JM; Garcia-Bustos V; García-Hita M; Valentín-Gómez E; Almaraz SG; de Groot PWJ; Pemán J
    Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of Two Novel Chromogenic Media for the Identification of Multidrug-Resistant Candida auris Compared with Other Commercially Available Formulations.
    de Jong AW; Dieleman C; Carbia M; Mohd Tap R; Hagen F
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33536293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the first Candida auris isolates reported from Türkiye in terms of identification by various methods and susceptibility to antifungal drugs.
    Erkose Genc G; Caklovica Kucukkaya I; Komec S; Toker Onder I; Toptas O; Teke L; Turan D; Aygun G; Gulmez D; Arikan Akdagli S; Erturan Z
    Indian J Med Microbiol; 2024; 49():100594. PubMed ID: 38636843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of CHROMagar™ Candida Plus chromogenic agar for the presumptive identification of Candida auris.
    Tamura T; Alshahni MM; Makimura K
    Microbiol Immunol; 2022 Jun; 66(6):292-298. PubMed ID: 35229341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a novel chromogenic medium for Candida spp. identification and comparison with CHROMagar™ Candida for the detection of Candida auris in surveillance samples.
    Mulet Bayona JV; Salvador García C; Tormo Palop N; Gimeno Cardona C
    Diagn Microbiol Infect Dis; 2020 Dec; 98(4):115168. PubMed ID: 32927410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tools for Detecting a "Superbug": Updates on Candida auris Testing.
    Lockhart SR; Lyman MM; Sexton DJ
    J Clin Microbiol; 2022 May; 60(5):e0080821. PubMed ID: 34985980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposal for a screening protocol for Candida auris colonization.
    Leonhard SE; Chong GM; Foudraine DE; Bode LGM; Croughs P; Popping S; Schaftenaar E; Klaassen CHW; Severin JA
    J Hosp Infect; 2024 Apr; 146():31-36. PubMed ID: 38286238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a new T2 Magnetic Resonance assay for rapid detection of emergent fungal pathogen Candida auris on clinical skin swab samples.
    Sexton DJ; Bentz ML; Welsh RM; Litvintseva AP
    Mycoses; 2018 Oct; 61(10):786-790. PubMed ID: 29938838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait.
    Khan Z; Ahmad S; Al-Sweih N; Joseph L; Alfouzan W; Asadzadeh M
    PLoS One; 2018; 13(4):e0195743. PubMed ID: 29630658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple low cost differentiation of Candida auris from Candida haemulonii complex using CHROMagar Candida medium supplemented with Pal's medium.
    Kumar A; Sachu A; Mohan K; Vinod V; Dinesh K; Karim S
    Rev Iberoam Micol; 2017; 34(2):109-111. PubMed ID: 28392225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of CHROMagar™ Candida Plus for presumptive identification of Candida auris from surveillance samples.
    Marathe A; Zhu Y; Chaturvedi V; Chaturvedi S
    Mycopathologia; 2022 Dec; 187(5-6):527-534. PubMed ID: 36355325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a qualitative real-time PCR assay for the detection of
    Franco LC; Ahmed M; Kendra CG; Sperling RM; Van Benten K; Lavik J-P; Emery CL; Relich RF; Gavina K
    J Clin Microbiol; 2024 Jun; 62(6):e0015824. PubMed ID: 38690882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a reformulated CHROMagar Candida.
    Jabra-Rizk MA; Brenner TM; Romagnoli M; Baqui AA; Merz WG; Falkler WA; Meiller TF
    J Clin Microbiol; 2001 May; 39(5):2015-6. PubMed ID: 11326038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species.
    Odds FC; Bernaerts R
    J Clin Microbiol; 1994 Aug; 32(8):1923-9. PubMed ID: 7989544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Detection of Emergent Fungal Pathogen Candida auris in Clinical Skin Swabs by SYBR Green-Based Quantitative PCR Assay.
    Sexton DJ; Kordalewska M; Bentz ML; Welsh RM; Perlin DS; Litvintseva AP
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30232130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rezafungin
    Helleberg M; Jørgensen KM; Hare RK; Datcu R; Chowdhary A; Arendrup MC
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex Vivo Human and Porcine Skin Effectively Model Candida auris Colonization, Differentiating Robust and Poor Fungal Colonizers.
    Eix EF; Johnson CJ; Wartman KM; Kernien JF; Meudt JJ; Shanmuganayagam D; Gibson ALF; Nett JE
    J Infect Dis; 2022 May; 225(10):1791-1795. PubMed ID: 35267041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.